VYVGART is an FDA-approved treatment for adults with anti-AChR antibody positive generalized myasthenia gravis (gMG).

Infusion Experience

VYVGART is given in treatment cycles of a 1-hour infusion each week for 4 weeks (4 infusions total).

During each infusion a healthcare professional will:

  • Prepare VYVGART for infusion
  • Check your vital signs, including your pulse, blood pressure, and temperature
  • Find a vein in your arm and put in the intravenous (IV) line
  • Monitor you during and after your infusion

Your neurologist and insurance company will work together to determine where you will receive your infusions. It will most likely be at your neurologist’s office or an infusion center.

Possible Side Effects

VYVGART was safe in treating most clinical trial participants.  In the clinical trial, the following side effects were reported in at least 5% of participants on VYVGART and more frequently than in participants on placebo.

  • Respiratory tract infection
  • Headache
  • Urinary tract infection
  • Tingling sensation
  • Muscle pain

Most infections in participants on VYVGART were mild to moderate. Additionally, more patients on VYVGART vs placebo had blood side effects that were mild to moderate.